John Glenn Iradimed Corp (IRMD) insider trading activity

IRMD Quotes by TradingView

John Glenn is CHIEF FINANCIAL OFFICER of IRADIMED CORP. Currently has a direct ownership of 6,883 shares of IRMD, which is worth approximately $330,246. The most recent transaction as insider was on Jun 20, 2023, when has been sold 1,412 shares (Common Stock) at a price of $47.88 per share, resulting in proceeds of $67,606. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.88K
0% 3M change
0% 12M change
Total Value Held $330,246

JOHN GLENN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2023
SELL
Payment of exercise price or tax liability
$67,606 $47.88 p/Share
1,412 Reduced 17.02%
6,883 Common Stock
Jun 20 2023
BUY
Exercise of conversion of derivative security
-
5,795 Added 41.13%
8,295 Common Stock
Dec 15 2022
BUY
Grant, award, or other acquisition
$71,675 $28.67 p/Share
2,500 Added 50.0%
2,500 Common Stock

Also insider at

EKSO
EKSO BIONICS HOLDINGS, INC. Healthcare
Chief Financial Officer
JG

John Glenn

CHIEF FINANCIAL OFFICER
Richmond, CA

Track Institutional and Insider Activities on IRMD

Follow IRADIMED CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRMD shares.

Notify only if

Insider Trading

Get notified when an Iradimed Corp insider buys or sells IRMD shares.

Notify only if

News

Receive news related to IRADIMED CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IRMD